Teal Enhancements for Cross-Industry Adoption

Project Scope

Research: Conduct a detailed analysis of the current teal framework and identify areas where flexibility can be introduced. A Proof-of-Concept will be provided after research. Development: Create new functionalities that allow for the re-formatting, post-processing, and decoration of outputs generated by existing teal modules.Testing: Develop test cases to ensure the new functionalities are compatible with existing modules and meet the customisation needs of different companies.Documentation: Update the framework's documentation to include instructions on how to use the new features.Training & Support: Provide training and ongoing support to users within the pharma industry to facilitate the adoption of the enhanced teal framework.

Problem Statement

The teal framework has provided significant value to the pharma community via its power of interactive data exploration in clinical trials and beyond, together with its pre-built modules in teal.modules.clinical, which analyse standardised clinical data and generate outputs that meet general industry standards. However, the industry's varied standards and analysis needs may pose a limitation to wider adoption of teal across different companies. Sometimes this has led to the need for companies to develop their own ad hoc clinical modules from scratch to meet their specific requirements, which can be resource-intensive and inefficient. The proposed project seeks to address this challenge by enhancing features and flexibilities of the teal framework. With these enhancements, users can tailor the output formatting and presentation without modifying the core modules, ensuring that the framework remains widely usable across different companies while reducing the overhead of custom module development.

Problem Impact

The project aims to introduce enhanced flexibility into the teal framework. By adding new functionalities that allow users to re-format, post-process, and decorate outputs generated by any teal module, the project will enable the pharmaceutical industry to standardise outputs according to individual company requirements without the need to develop custom modules from scratch. This will also empower the reusability and scalability of existing modules across different companies.

Key Benefits:

  • Streamlined processes for generating customised tables, listings, and graphs (TLGs).
  • Reduced need for bespoke module development.
  • Increased adoption and utility of the teal framework across various pharmaceutical companies.
  • Enhanced standardisation across the industry, promoting efficiency and consistency.

Project Leads

Email

Peyman Eshghi, Johnson & Johnson

peshghi@its.jnj.com

Nina Qi

qi.ting@gene.com

Nicholas Masel, Johnson & Johnson

nmasel@its.jnj.com
Alex Pearce, PHUSE Project Assistant

alexandra@phuse.global

CURRENT STATUS Q3 2024

  • New Project, currently calling for volunteers. 
Objectives & DeliverablesTimelines
Project Initiation and requirements gatheringQ4 2024

Development of flexibility features

Q2 2025
Initial testing and debuggingQ3 2025
User acceptance testing and final adjustmentsQ4 2025
Documentation, training and deploymentQ1 2025